First Monday - Szabolcs Nagy (Turbine AI)

HubHub - Király utca 26. Budapest, 1061 - View Map Budapest
Mon, Feb 7, 6:00 PM (CET)

Join a special edition of First Monday (In-person) on February 7th. We are joining Startup Hungary's flagship event series as partners, to work together for a more connected startup ecosystem. We also have an exciting announcement to share, and you don't want to miss this. Ready for some startup vibe? Register and let's meet.

About this event

Join a special edition of First Monday (In-person) on February 7th. We are joining Startup Hungary's flagship event series as partners, to work together for a more connected startup ecosystem. We also have an exciting announcement to share, and you don't want to miss this. Ready for some startup vibe? Register and let's meet.

On February 7th, at the next First Monday event, we will have Szabolcs Nagy, the CEO & Co-Founder of Turbine AI with us to discuss how the company was started, what challenges they overcame as a deep tech startup out of Hungary & and how they are contributing to the future of drug discovery!

Learn more about the journey of one of the hottest regional biotech companies.

Turbine was founded by Kristof Szalay, Daniel Veres, and Szabolcs Nagy in 2015 to create a simulation-based, AI-driven, scalable drug discovery platform. The company’s Simulated Cell unlocks novel therapies for high unmet oncology. Their technology has been validated in several collaborations with pharmaceutical companies such as Bayer. At the end of 2020, they raised a $6.9M pre-Series A round led by Accel Partners.

😷 Please only join this event if you are vaccinated or if you have a recent negative PCR test. Masks will be available, and it will be mandatory to wear them. Safety is a priority for everyone, if you feel sick or have symptoms, please stay home and we hope to see you at our next event. 😷

Startup

Turbine

Turbine was founded by Kristof Szalay, Daniel Veres, and Szabolcs Nagy in 2015 to create a simulation-based, AI-driven, scalable drug discovery platform. The company’s Simulated Cell unlocks novel therapies for high unmet oncology. Their technology has been validated in several collaborations with pharmaceutical companies such as Bayer. At the end of 2020, they raised a $6.9M pre-Series A round.

When

Monday, Feb 7
6:00 PM - 9:30 PM (CET)

Where

HubHub
Király utca 26. Budapest1061

Brought to you by

  • Csongor Biás

    Csongor Biás

    Startup Hungary

    Managing Director

    See Bio

Brought to you by

Partners